Digital Twin–Guided VT Ablation Shows Early Feasibility

Key Takeaways:

• A small NEJM-reported feasibility study (n=10) evaluated MRI-based “digital twin” simulations to guide VT ablation in post–myocardial infarction patients.
• Digital twin–derived targets were integrated into procedural navigation, with all patients noninducible at procedure end (a procedural endpoint).
• Follow-up findings are described as favorable but are based on a small, uncontrolled cohort, with larger studies needed to assess clinical effectiveness.

A NEJM correspondence reports on the TWIN-VT study, in which Johns Hopkins investigators used patient-specific, MRI-derived “digital twin” heart simulations to plan catheter ablation for ventricular tachycardia (VT) in patients with prior myocardial infarction. The report describes a small, early-phase feasibility series of 10 participants, presenting a workflow that links preprocedural simulation with intraprocedural targeting and follow-up observations.

Participants were described as individuals with prior myocardial infarction and VT, a population in which identifying arrhythmogenic substrate can be challenging during standard ablation. The “digital twin” approach involved constructing a personalized computational model of each patient’s heart from contrast-enhanced MRI, simulating electrical activity to identify regions likely to sustain VT, and using these predictions to guide ablation strategy. The report focuses on this integration of imaging-derived modeling with procedural planning rather than on subgroup-specific analyses.

In procedural application, predicted targets from the digital twin simulations were incorporated into the electrophysiology lab’s navigation system to guide mapping and ablation. Investigators describe using the model to test treatment scenarios in advance and to focus ablation on predicted critical regions. This workflow is presented as a feasibility demonstration of integrating simulation output into real-time procedural guidance.

As reported, all patients were noninducible for VT at the end of the ablation procedure, a standard procedural endpoint. During follow-up extending beyond one year, the report describes no recurrent VT episodes, with attribution to the study authors; however, these findings are based on a small, uncontrolled cohort. Two patients experienced brief early post-procedure episodes during the healing phase, and antiarrhythmic therapy was reduced or discontinued in most participants, as described in the report.

Overall, the correspondence presents early feasibility and signal-generating results for MRI-based digital twin–guided VT ablation. The authors emphasize the need for larger studies to evaluate effectiveness, reproducibility, and scalability, including efforts to streamline model generation and integrate the approach into broader clinical workflows.